Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
9 Meters Biopharma, Inc. (NMTR)
NASDAQ:NMTR
Holding NMTR?
Track your performance easily
NMTR Stock Chart & Stats
Day’s Range$0.07 - $0.11
52-Week Range― - ―
Previous Close$0.13
Volume9.96M
Average Volume (3M)N/A
Market Cap
$1.83M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding14,459,690
10 Day Avg. Volume2,832,758
30 Day Avg. Volume970,565
Standard Deviation0.26
R-Squared0.08
Alpha-0.08
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)-0.06
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$0.75Price Target Upside938.78% Upside
Rating ConsensusHold
Number of Analyst Covering3
9 Meters Biopharma News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
NMTR FAQ
What was 9 Meters Biopharma, Inc.’s price range in the past 12 months?
Currently, no data Available
What is 9 Meters Biopharma, Inc.’s market cap?
Currently, no data Available
When is 9 Meters Biopharma, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were 9 Meters Biopharma, Inc.’s earnings last quarter?
Currently, no data Available
Is 9 Meters Biopharma, Inc. overvalued?
According to Wall Street analysts 9 Meters Biopharma, Inc.’s price is currently Undervalued.
Does 9 Meters Biopharma, Inc. pay dividends?
9 Meters Biopharma, Inc. does not currently pay dividends.
What is 9 Meters Biopharma, Inc.’s EPS estimate?
9 Meters Biopharma, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does 9 Meters Biopharma, Inc. have?
Currently, no data Available
What happened to 9 Meters Biopharma, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of 9 Meters Biopharma, Inc.?
Currently, no hedge funds are holding shares in NMTR
---
9 Meters Biopharma Stock Smart Score
Company Description
9 Meters Biopharma, Inc.
Innovate Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It foucs on developing novel medicines for autoimmune inflammatory disease. The company is founded by Jay P. Madan and Kendyle Woodard in 2012 and is headquartered in Raleigh, NC.
---
NMTR Stock 12 Month Forecast
Average Price Target
$0.75
▲(938.78% Upside)
Technical Analysis
---